Alejandro Martínez León

Alejandro Martínez León

Auto-generated profile, based on publicly available information

Alejandro Martínez León

Saarland University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
Riccardo VernuccioRiccardo Vernuccio
Riccardo Vernuccio
ALAlejandro Martínez León
Alejandro Martínez León
Chetan PoojariChetan Poojari
Chetan Poojari
JBJulian Buchrieser
Julian Buchrieser
CSChristopher N. Selverian
Christopher N. Selverian
Pablo Guardado-CalvoPablo Guardado-Calvo
Pablo Guardado-Calvo
Mpox is a zoonotic disease endemic to Central and West Africa. Since 2022, two human-adapted monkeypox virus (MPXV) strains have caused large outbreaks outside these regions. Tecovirimat is the most widely used drug to treat mpox. It blocks viral egress by targeting the viral phospholipase F13; however, the structural details are unknown, and mutations in the F13 gene can result in resistance against tecovirimat, raising public health concerns. Here we report the structure of an F13 homodimer using X-ray crystallography, both alone (2.1 Å) and in complex with tecovirimat (2.6 Å). Combined with molecular dynamics simulations and dimerization assays, we show that tecovirimat acts as a molecular glue that promotes dimerization of the phospholipase. Tecovirimat resistance mutations identified in clinical MPXV isolates map to the F13 dimer interface and prevent drug-induced dimerization in solution and in cells. These findings explain how tecovirimat works, allow for better monitoring of resistant MPXV strains and pave the way for developing more potent and resilient therapeutics.

23 September 2024 in Research Square
Verified
Preprint
Open access
PDF file
Riccardo VernuccioRiccardo Vernuccio
Riccardo Vernuccio
ALAlejandro Martínez León
Alejandro Martínez León
Chetan PoojariChetan Poojari
Chetan Poojari
JBJulian Buchrieser
Julian Buchrieser
CSChristopher Selverian
Christopher Selverian
PGPablo Guardado-Calvo
Pablo Guardado-Calvo
Mpox is a zoonotic disease endemic in central and west Africa. However, since 2022, human-adapted mpox virus (MPXV) strains are causing large outbreaks spreading outside these regions, leading the World Health Organization to declare public health emergency twice. Tecovirimat, the most widely used drug to treat these infections, blocks viral egress through a poorly understood mechanism. Tecovirimat-resistant strains, all with mutations in the viral phospholipase F13, pose public health concerns. Herein, we report the structure of an F13 homodimer, both alone and in complex with tecovirimat. We demonstrate that tecovirimat acts as a molecular glue, inducing the dimerization of the phospholipase. F13 escape mutations in MPXV clinical isolates are at the dimer interface and prevent drug-induced dimerization in solution and cells. These findings, which decipher tecovirimat's mode of action, will allow better monitoring of poxvirus outbreaks and pave the way for developing more potent and resilient therapeutics.

7 January 2026 in Journal of Chemical Theory and Computation
Verified
Journal Article
Open access
ALAlejandro Martínez León
Alejandro Martínez León
LALucas Andersen
Lucas Andersen
JHJochen S. Hub
Jochen S. Hub
We present BindFlow, a Python-based software for automated absolute binding free energy (ABFE) calculations at the free energy perturbation (FEP) or at the molecular mechanics Poisson-Boltzmann/generalized Born surface area [MM(PB/GB)SA] level of theory. BindFlow is free, open-source, user-friendly, and easily customizable, runs on workstations or distributed computing platforms, and provides extensive documentation and tutorials. BindFlow uses GROMACS as a molecular dynamics engine and provides built-in support for the small-molecule force fields GAFF, OpenFF, and Espaloma, as well as support for user-provided custom force fields. We test BindFlow by computing affinities for 139 receptor-ligand pairs, involving eight different targets, including six soluble proteins, one membrane protein, and one nonprotein host-guest system. We find that the agreement of BindFlow predictions with experiments is overall similar to gold standards in the field. Interestingly, we find that MM(PB/GB)SA achieves correlations that, for some systems and force fields, approach those obtained with FEP while requiring only a fraction of the computational cost. This study establishes BindFlow as a validated and accessible tool for ABFE calculations.

27 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
LALucas Andersen
Lucas Andersen
MRMax Rausch-Dupont
Max Rausch-Dupont
ALAlejandro Martínez León
Alejandro Martínez León
AVAndrea Volkamer
Andrea Volkamer
JHJochen S. Hub
Jochen S. Hub
DKDietrich Klakow
Dietrich Klakow
Predicting protein–ligand binding affinity with high accuracy is critical in structure-based drug discovery. While docking methods offer computational efficiency, they often lack the precision required for reliable affinity ranking. In contrast, molecular dynamics (MD)-based approaches such as MMGBSA provide more accurate binding free energy estimates but are computationally intensive, limiting their scalability. To address this trade-off, we introduce an active learning framework that automates molecule selection for docking and MD simulations, replacing manual expert-driven decisions with a data-efficient, model-guided strategy. Our approach integrates fixed — partly pre-trained deep learning — molecular embeddings (MolFormer, ChemBERTa-2, and Morgan fingerprints) with adaptive regression models (e.g. Bayesian Ridge and Random Forest) to iteratively improve binding affinity predictions. We evaluate this approach retro-spectively on a new dataset of 59,356 chemically diverse compounds from ZINC-22 targeting the MCL1 protein using both AutoDock Vina and MMGBSA binding free energy scores. Our results show that incorporating MMGBSA scores into the active learning loop significantly enhances performance, recovering 79.9% of the top 1% binders in the whole dataset, compared to only 6.7% when using docking scores alone. Notably, MMGBSA exhibits a stronger correlation with experimental binding affinities than AutoDock Vina on our dataset and enables more accurate ranking of candidate compounds in a runtime efficient way. Furthermore, we demonstrate that a one-at-a-time acquisition active learning strategy consistently outperforms traditional batched acquisition, the latter achieving just 78.4% recovery with MolFormer and Bayesian Ridge. These findings underscore the potential of integrating deep learning-based molecular representations with MD-level accuracy in an active learning framework, offering a scalable and efficient path to accelerate virtual screening and improve hit identification in drug discovery.

27 September 2025 in bioRxiv
Verified
Preprint
Open access
ALAlejandro Martínez León
Alejandro Martínez León
LALucas Andersen
Lucas Andersen
JHJochen S. Hub
Jochen S. Hub
We present BindFlow, a Python-based software for automated absolute binding free energy (ABFE) calculations at the free energy perturbation (FEP) or at the molecular mechanics Poisson-Boltzmann/generalized Born surface area [MM(PB/GB)SA] level of theory. BindFlow is free, open-source, user-friendly, easily customizable, runs on work-stations or distributed computing platforms, and provides extensive documentation and tutorials. BindFlow uses GROMACS as molecular dynamics engine and provides built-in support for the small-molecule force fields GAFF, OpenFF, and Espaloma. We test BindFlow by computing affinities for 139 ligand/target pairs, involving eight different targets including six soluble proteins, one membrane protein and one non-protein host– guest system. Quantified by Pearson, Kendall, and Spearman correlations coefficients, we find that the agreement of BindFlow predictions with experiments are overall similar to gold standards in the field. Interestingly, we find that MM(PB/GB)SA achieves correlations that, for some systems and force fields, approach those obtained with FEP, while requiring only a fraction of the computational cost. This study establishes BindFlow as a validated and accessible tool for ABFE calculations.

13 June 2026 in Digital Discovery
Verified
Journal Article
Open access
PDF file
LALucas Andersen
Lucas Andersen
MRMax Rausch-Dupont
Max Rausch-Dupont
ALAlejandro Martínez León
Alejandro Martínez León
AVAndrea Volkamer
Andrea Volkamer
JHJochen S. Hub
Jochen S. Hub
DKDietrich Klakow
Dietrich Klakow
Combination of MD simulations with an active learning pipeline to bring an MD-level of accuracy to the drug discovery process of identifying the most potent binders. Evaluated on 60.000 computationally derived binding affinities of the MCL1 protein.